Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Helius Medical Tech Stock (NASDAQ: HSDT) stock price, news, charts, stock research, profile.
Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.000 | -3.000 | 3.0000 | ||||
REV | 190.000K | 256.000K | 66.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-12-20 | Maxim Group | Anthony Vendetti | Initiates Coverage On | Buy | Announces | - | 1.00 |
2022-08-23 | Roth Capital | Jonathan Aschoff | Initiates Coverage On | Buy | Announces | - | 5.00 |
2021-11-15 | Noble Capital Markets | Joe Gomes | Downgrades | OutperformMarket Perform | - | - | - |
2021-03-24 | Noble Capital Markets | Joe Gomes | Initiates Coverage On | Outperform | Announces | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSDT | Helius Medical Tech | 11.3% | 5.1M |
VTAK | Catheter Precision | -4.27% | 3M |
NDRA | ENDRA Life Sciences | 1.9% | 8M |
BJDX | Bluejay Diagnostics | -21.47% | 5.6M |
NXL | Nexalin Technology | 0.75% | 3.5M |
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
Other companies in Helius Medical Tech’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on Tuesday, December 20, 2022. The analyst firm set a price target for 1.00 expecting HSDT to fall to within 12 months (a possible -88.84% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $8.96 last updated September 27, 2023 at 8:00 PM UTC.
There is no dividend information for Helius Medical Tech.
Helius Medical Tech’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Helius Medical Tech Stock (NASDAQ: HSDT) stock price, news, charts, stock research, profile.
Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.000 | -3.000 | 3.0000 | ||||
REV | 190.000K | 256.000K | 66.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-12-20 | Maxim Group | Anthony Vendetti | Initiates Coverage On | Buy | Announces | - | 1.00 |
2022-08-23 | Roth Capital | Jonathan Aschoff | Initiates Coverage On | Buy | Announces | - | 5.00 |
2021-11-15 | Noble Capital Markets | Joe Gomes | Downgrades | OutperformMarket Perform | - | - | - |
2021-03-24 | Noble Capital Markets | Joe Gomes | Initiates Coverage On | Outperform | Announces | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSDT | Helius Medical Tech | 11.3% | 5.1M |
VTAK | Catheter Precision | -4.27% | 3M |
NDRA | ENDRA Life Sciences | 1.9% | 8M |
BJDX | Bluejay Diagnostics | -21.47% | 5.6M |
NXL | Nexalin Technology | 0.75% | 3.5M |
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
Other companies in Helius Medical Tech’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on Tuesday, December 20, 2022. The analyst firm set a price target for 1.00 expecting HSDT to fall to within 12 months (a possible -88.84% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $8.96 last updated September 27, 2023 at 8:00 PM UTC.
There is no dividend information for Helius Medical Tech.
Helius Medical Tech’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Helius Medical Tech Stock (NASDAQ: HSDT) stock price, news, charts, stock research, profile.
Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.000 | -3.000 | 3.0000 | ||||
REV | 190.000K | 256.000K | 66.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-12-20 | Maxim Group | Anthony Vendetti | Initiates Coverage On | Buy | Announces | - | 1.00 |
2022-08-23 | Roth Capital | Jonathan Aschoff | Initiates Coverage On | Buy | Announces | - | 5.00 |
2021-11-15 | Noble Capital Markets | Joe Gomes | Downgrades | OutperformMarket Perform | - | - | - |
2021-03-24 | Noble Capital Markets | Joe Gomes | Initiates Coverage On | Outperform | Announces | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSDT | Helius Medical Tech | 11.3% | 5.1M |
VTAK | Catheter Precision | -4.27% | 3M |
NDRA | ENDRA Life Sciences | 1.9% | 8M |
BJDX | Bluejay Diagnostics | -21.47% | 5.6M |
NXL | Nexalin Technology | 0.75% | 3.5M |
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
Other companies in Helius Medical Tech’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on Tuesday, December 20, 2022. The analyst firm set a price target for 1.00 expecting HSDT to fall to within 12 months (a possible -88.84% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $8.96 last updated September 27, 2023 at 8:00 PM UTC.
There is no dividend information for Helius Medical Tech.
Helius Medical Tech’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Helius Medical Tech Stock (NASDAQ: HSDT) stock price, news, charts, stock research, profile.
Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.000 | -3.000 | 3.0000 | ||||
REV | 190.000K | 256.000K | 66.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-12-20 | Maxim Group | Anthony Vendetti | Initiates Coverage On | Buy | Announces | - | 1.00 |
2022-08-23 | Roth Capital | Jonathan Aschoff | Initiates Coverage On | Buy | Announces | - | 5.00 |
2021-11-15 | Noble Capital Markets | Joe Gomes | Downgrades | OutperformMarket Perform | - | - | - |
2021-03-24 | Noble Capital Markets | Joe Gomes | Initiates Coverage On | Outperform | Announces | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSDT | Helius Medical Tech | 11.3% | 5.1M |
VTAK | Catheter Precision | -4.27% | 3M |
NDRA | ENDRA Life Sciences | 1.9% | 8M |
BJDX | Bluejay Diagnostics | -21.47% | 5.6M |
NXL | Nexalin Technology | 0.75% | 3.5M |
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
Other companies in Helius Medical Tech’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on Tuesday, December 20, 2022. The analyst firm set a price target for 1.00 expecting HSDT to fall to within 12 months (a possible -88.84% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $8.96 last updated September 27, 2023 at 8:00 PM UTC.
There is no dividend information for Helius Medical Tech.
Helius Medical Tech’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Helius Medical Tech Stock (NASDAQ: HSDT) stock price, news, charts, stock research, profile.
Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.000 | -3.000 | 3.0000 | ||||
REV | 190.000K | 256.000K | 66.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-12-20 | Maxim Group | Anthony Vendetti | Initiates Coverage On | Buy | Announces | - | 1.00 |
2022-08-23 | Roth Capital | Jonathan Aschoff | Initiates Coverage On | Buy | Announces | - | 5.00 |
2021-11-15 | Noble Capital Markets | Joe Gomes | Downgrades | OutperformMarket Perform | - | - | - |
2021-03-24 | Noble Capital Markets | Joe Gomes | Initiates Coverage On | Outperform | Announces | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSDT | Helius Medical Tech | 11.3% | 5.1M |
VTAK | Catheter Precision | -4.27% | 3M |
NDRA | ENDRA Life Sciences | 1.9% | 8M |
BJDX | Bluejay Diagnostics | -21.47% | 5.6M |
NXL | Nexalin Technology | 0.75% | 3.5M |
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
Other companies in Helius Medical Tech’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on Tuesday, December 20, 2022. The analyst firm set a price target for 1.00 expecting HSDT to fall to within 12 months (a possible -88.84% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $8.96 last updated September 27, 2023 at 8:00 PM UTC.
There is no dividend information for Helius Medical Tech.
Helius Medical Tech’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Helius Medical Tech Stock (NASDAQ: HSDT) stock price, news, charts, stock research, profile.
Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.000 | -3.000 | 3.0000 | ||||
REV | 190.000K | 256.000K | 66.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-12-20 | Maxim Group | Anthony Vendetti | Initiates Coverage On | Buy | Announces | - | 1.00 |
2022-08-23 | Roth Capital | Jonathan Aschoff | Initiates Coverage On | Buy | Announces | - | 5.00 |
2021-11-15 | Noble Capital Markets | Joe Gomes | Downgrades | OutperformMarket Perform | - | - | - |
2021-03-24 | Noble Capital Markets | Joe Gomes | Initiates Coverage On | Outperform | Announces | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSDT | Helius Medical Tech | 11.3% | 5.1M |
VTAK | Catheter Precision | -4.27% | 3M |
NDRA | ENDRA Life Sciences | 1.9% | 8M |
BJDX | Bluejay Diagnostics | -21.47% | 5.6M |
NXL | Nexalin Technology | 0.75% | 3.5M |
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
Other companies in Helius Medical Tech’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on Tuesday, December 20, 2022. The analyst firm set a price target for 1.00 expecting HSDT to fall to within 12 months (a possible -88.84% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $8.96 last updated September 27, 2023 at 8:00 PM UTC.
There is no dividend information for Helius Medical Tech.
Helius Medical Tech’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Helius Medical Tech Stock (NASDAQ: HSDT) stock price, news, charts, stock research, profile.
Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.000 | -3.000 | 3.0000 | ||||
REV | 190.000K | 256.000K | 66.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-12-20 | Maxim Group | Anthony Vendetti | Initiates Coverage On | Buy | Announces | - | 1.00 |
2022-08-23 | Roth Capital | Jonathan Aschoff | Initiates Coverage On | Buy | Announces | - | 5.00 |
2021-11-15 | Noble Capital Markets | Joe Gomes | Downgrades | OutperformMarket Perform | - | - | - |
2021-03-24 | Noble Capital Markets | Joe Gomes | Initiates Coverage On | Outperform | Announces | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSDT | Helius Medical Tech | 11.3% | 5.1M |
VTAK | Catheter Precision | -4.27% | 3M |
NDRA | ENDRA Life Sciences | 1.9% | 8M |
BJDX | Bluejay Diagnostics | -21.47% | 5.6M |
NXL | Nexalin Technology | 0.75% | 3.5M |
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
Other companies in Helius Medical Tech’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on Tuesday, December 20, 2022. The analyst firm set a price target for 1.00 expecting HSDT to fall to within 12 months (a possible -88.84% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $8.96 last updated September 27, 2023 at 8:00 PM UTC.
There is no dividend information for Helius Medical Tech.
Helius Medical Tech’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Helius Medical Tech Stock (NASDAQ: HSDT) stock price, news, charts, stock research, profile.
Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.000 | -3.000 | 3.0000 | ||||
REV | 190.000K | 256.000K | 66.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-12-20 | Maxim Group | Anthony Vendetti | Initiates Coverage On | Buy | Announces | - | 1.00 |
2022-08-23 | Roth Capital | Jonathan Aschoff | Initiates Coverage On | Buy | Announces | - | 5.00 |
2021-11-15 | Noble Capital Markets | Joe Gomes | Downgrades | OutperformMarket Perform | - | - | - |
2021-03-24 | Noble Capital Markets | Joe Gomes | Initiates Coverage On | Outperform | Announces | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSDT | Helius Medical Tech | 11.3% | 5.1M |
VTAK | Catheter Precision | -4.27% | 3M |
NDRA | ENDRA Life Sciences | 1.9% | 8M |
BJDX | Bluejay Diagnostics | -21.47% | 5.6M |
NXL | Nexalin Technology | 0.75% | 3.5M |
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
Other companies in Helius Medical Tech’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on Tuesday, December 20, 2022. The analyst firm set a price target for 1.00 expecting HSDT to fall to within 12 months (a possible -88.84% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $8.96 last updated September 27, 2023 at 8:00 PM UTC.
There is no dividend information for Helius Medical Tech.
Helius Medical Tech’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Helius Medical Tech Stock (NASDAQ: HSDT) stock price, news, charts, stock research, profile.
Open7.890 | Close8.960 |
Vol / Avg.50.001K / 391.117K | Mkt Cap5.071M |
Day Range7.890 - 9.000 | 52 Wk Range5.690 - 20.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.000 | -3.000 | 3.0000 | ||||
REV | 190.000K | 256.000K | 66.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-12-20 | Maxim Group | Anthony Vendetti | Initiates Coverage On | Buy | Announces | - | 1.00 |
2022-08-23 | Roth Capital | Jonathan Aschoff | Initiates Coverage On | Buy | Announces | - | 5.00 |
2021-11-15 | Noble Capital Markets | Joe Gomes | Downgrades | OutperformMarket Perform | - | - | - |
2021-03-24 | Noble Capital Markets | Joe Gomes | Initiates Coverage On | Outperform | Announces | - | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HSDT | Helius Medical Tech | 11.3% | 5.1M |
VTAK | Catheter Precision | -4.27% | 3M |
NDRA | ENDRA Life Sciences | 1.9% | 8M |
BJDX | Bluejay Diagnostics | -21.47% | 5.6M |
NXL | Nexalin Technology | 0.75% | 3.5M |
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
Other companies in Helius Medical Tech’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Nexalin Technology (NASDAQ:NXL) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Maxim Group on Tuesday, December 20, 2022. The analyst firm set a price target for 1.00 expecting HSDT to fall to within 12 months (a possible -88.84% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $8.96 last updated September 27, 2023 at 8:00 PM UTC.
There is no dividend information for Helius Medical Tech.
Helius Medical Tech’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.